| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...729957D |
| P356 | DOI | 10.1371/JOURNAL.PONE.0029957 |
| P932 | PMC publication ID | 3303773 |
| P698 | PubMed publication ID | 22431958 |
| P5875 | ResearchGate publication ID | 221724528 |
| P50 | author | Izabela A Rodenhuis-Zybert | Q54029667 |
| Tonya M Colpitts | Q54435531 | ||
| Jan Wilschut | Q87375573 | ||
| Jolanda M Smit | Q98238255 | ||
| Júlia M da Silva Voorham | Q115215342 | ||
| Erol Fikrig | Q28355961 | ||
| Heidi van der Ende-Metselaar | Q46151194 | ||
| Michael S. Diamond | Q28051146 | ||
| P2093 | author name string | Nilda Vanesa Ayala Nuñez | |
| P2860 | cites work | Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions | Q54197414 |
| Cross-reacting antibodies enhance dengue virus infection in humans | Q28281588 | ||
| A structural perspective of the flavivirus life cycle | Q29616269 | ||
| Conformational changes of the flavivirus E glycoprotein | Q29618170 | ||
| Neutralization and antibody-dependent enhancement of dengue viruses | Q29618172 | ||
| Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM | Q29618178 | ||
| Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants | Q29620637 | ||
| Immunopathogenesis of dengue virus infection | Q33338908 | ||
| In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions | Q33727990 | ||
| Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles | Q34046013 | ||
| Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. | Q34120070 | ||
| The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity | Q37448171 | ||
| Functional importance of dengue virus maturation: infectious properties of immature virions | Q39917068 | ||
| Characterization of the functional requirements of West Nile virus membrane fusion | Q40377031 | ||
| Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. | Q40468928 | ||
| Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones | Q40567953 | ||
| Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus | Q40676556 | ||
| Antibody-enhanced dengue virus infection in primate leukocytes | Q40884212 | ||
| The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein | Q42980684 | ||
| ??? | Q27006626 | ||
| Structure of dengue virus: implications for flavivirus organization, maturation, and fusion | Q24736810 | ||
| Infection of human cells by dengue virus is modulated by different cell types and viral strains | Q27469687 | ||
| Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E | Q27469788 | ||
| Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells | Q27469935 | ||
| Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum | Q27472959 | ||
| Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus | Q27473288 | ||
| Structures of immature flavivirus particles | Q27477478 | ||
| Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites | Q27477542 | ||
| A ligand-binding pocket in the dengue virus envelope glycoprotein | Q27477685 | ||
| Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein | Q27477718 | ||
| Structure of Immature West Nile Virus | Q27480359 | ||
| Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking | Q27484978 | ||
| Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus | Q27484980 | ||
| Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization | Q27485890 | ||
| Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1 | Q27486610 | ||
| Differential Modulation of prM Cleavage, Extracellular Particle Distribution, and Virus Infectivity by Conserved Residues at Nonfurin Consensus Positions of the Dengue Virus pr-M Junction | Q27487116 | ||
| The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection | Q27488224 | ||
| Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens | Q27488243 | ||
| Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored | Q27489549 | ||
| IL-10 Signaling Blockade Controls Murine West Nile Virus Infection | Q27489722 | ||
| Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody | Q27490283 | ||
| Immature Dengue Virus: A Veiled Pathogen? | Q27490592 | ||
| Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient | Q27490987 | ||
| Structure of the dengue virus envelope protein after membrane fusion | Q27643009 | ||
| Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation | Q27643140 | ||
| The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution | Q27730234 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| Dengue virus | Q476209 | ||
| infectivity | Q1662346 | ||
| P304 | page(s) | e29957 | |
| P577 | publication date | 2012-03-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2 | |
| P478 | volume | 7 |
| Q47194469 | A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice |
| Q35168403 | Antibodies against immature virions are not a discriminating factor for dengue disease severity |
| Q27468834 | Autophagy-associated dengue vesicles promote viral transmission avoiding antibody neutralization |
| Q37694852 | DENV-2 subunit proteins fused to CR2 receptor-binding domain (P28)-induces specific and neutralizing antibodies to the Dengue virus in mice. |
| Q58595152 | Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody |
| Q39126155 | Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage. |
| Q35535146 | Germinal center reaction following cutaneous dengue virus infection in immune-competent mice |
| Q34976206 | Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody |
| Q35179653 | Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN. |
| Q28085648 | Is transfusion-transmitted dengue fever a potential public health threat? |
| Q30392050 | Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients |
| Q38045381 | Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans |
| Q38646923 | New insights into the immunopathology and control of dengue virus infection |
| Q38636217 | Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development |
| Q24289014 | Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections |
| Q36234359 | Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection |
| Q40058562 | Seroprevalence of Asymptomatic Dengue Virus Infection and Its Antibodies Among Healthy/Eligible Saudi Blood Donors: Findings From Holy Makkah City |
| Q40238063 | Serotype-Specific Anti-Dengue Virus NS1 Mouse Antibodies Cross-React with prM and Are Potentially Involved in Virus Production |
| Q26700056 | The Cellular Bases of Antibody Responses during Dengue Virus Infection |
| Q90040549 | The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases |
| Q39090532 | The interaction between claudin-1 and dengue viral prM/M protein for its entry |
| Q26865618 | West Nile Virus: biology, transmission, and human infection |
| Q66679277 | Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice |
Search more.